HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus (Q74451704)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

systemic lupus erythematosus

1 reference

J F Viallard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Bloch-Michel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Neau-Cransac

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J L Taupin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Garrigue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

V Miossec

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Mercie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J L Pellegrin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J F Moreau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

485-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases

10 November 2019

cites work

1 reference

12 December 2020

Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares

1 reference

12 December 2020

CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity

1 reference

12 December 2020

Analysis of fine-needle aspiration biopsies by flow cytometry in kidney transplant patients

1 reference

12 December 2020

Immunologic factors and clinical activity in systemic lupus erythematosus

1 reference

12 December 2020

Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features

1 reference

12 December 2020

1 reference

12 December 2020

Immune Complexes, Complement, and Anti-DNA in Exacerbations of Systemic Lupus Erythematosus (SLE)

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Kinetic analysis of Ia expression on T cells in patients with systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

12 December 2020

OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions

1 reference

12 December 2020

Increased circulating HLA-DR+ CD4+ T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy

1 reference

12 December 2020

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

1 reference

12 December 2020

Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus

1 reference

12 December 2020

Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity

1 reference

12 December 2020

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

12 December 2020

SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up.

1 reference

12 December 2020

Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus

1 reference

12 December 2020

Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study

1 reference

12 December 2020

1 reference

12 December 2020

Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus

1 reference

12 December 2020

Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?

1 reference

12 December 2020

B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation

1 reference

12 December 2020

Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis

1 reference

12 December 2020

Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus.

1 reference

12 December 2020

B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus

1 reference

12 December 2020

Systemic lupus erythematosus

1 reference

12 December 2020

Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation

1 reference

12 December 2020

Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE)

1 reference

12 December 2020

10.1046/J.1365-2249.2001.01623.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11531958%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference